Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Merit Medical SystemsMMSI +2.42%83 EV-to-EBIT is 22.88 as of Jul. 28, 2026, which is 52% below its 10-year median of 47.18. GuruFocus rates MMSI with a GF Score™ of 83/100 and a GF Value™ of $97.32 (Modestly Undervalued). Among 466 Medical Devices & Instruments companies, Merit Medical Systems ranks worse than 61.8% on this metric.
Merit Medical Systems (NAS:MMSI) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Merit Medical Systems's Enterprise Value for the quarter that ended in Mar. 2026 was $4,446 Mil.
Merit Medical Systems's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $213 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Merit Medical Systems's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merit Medical Systems EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Merit Medical Systems's EV-to-EBIT falls into.
Merit Medical Systems's current Enterprise Value is $4,873 Mil.
Merit Medical Systems's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $213 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merit Medical Systems (MMSI) has a EV-to-EBIT of 22.88 as of Jul. 28, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Merit Medical Systems and its competitors. This is 52% below median its historical median of 47.18. According to the industry distribution chart, Merit Medical Systems ranks #288 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 61.8%.
Is Merit Medical Systems' EV-to-EBIT too high?
Merit Medical Systems' current EV-to-EBIT of 22.88 is 52% below median its 10-year median of 47.18. The Medical Devices & Instruments industry median EV-to-EBIT is 18.40. Merit Medical Systems' value of 22.88 is 24.4% above this industry median. Based on the distribution chart, Merit Medical Systems ranks #288 out of 466 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Merit Medical Systems has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' EV-to-EBIT compare to NVST and MMED?
According to the Medical Devices & Instruments industry distribution chart, Merit Medical Systems ranks #288 out of 466 companies for EV-to-EBIT. This places Merit Medical Systems in the lower half of its industry. The industry median EV-to-EBIT is 18.40. Merit Medical Systems' value of 22.88 is 24.4% above this benchmark. While the company's 10-year median is 47.18 vs. the industry median of 18.40, Merit Medical Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.40, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Merit Medical Systems's current EV-to-EBIT of 22.88 is 24.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Merit Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merit Medical Systems's current EV-to-EBIT is 22.88, which is 52% below median its own 10-year median of 47.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Merit Medical Systems (MMSI) is currently considered Modestly Undervalued. The stock's GF Value™ is $97.32, compared to a current price of $76.10 — trading 21.8% below its estimated fair value. The current EV-to-EBIT is 22.88, which is 52% below median its 10-year median of 47.18 and 24.4% above the Medical Devices & Instruments industry median of 18.40. Merit Medical Systems' overall GF Score™ is 83/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Merit Medical Systems (MMSI), the current EV-to-EBIT is 22.88 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merit Medical Systems (MMSI) Overvalued in 2026?
Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued.
The current stock price of $76.10 is trading 21.8% below its estimated GF Value™ of $97.32.
GuruFocus considers Merit Medical Systems to be Modestly Undervalued.
Key valuation signals for MMSI:
EV-to-EBIT: 22.88 (52% below median its 10-year median of 47.18)
GF Value™: $97.32 vs. price of $76.10 (21.8% below fair value)
Industry Position: 24.4% above the Medical Devices & Instruments median (#288 of 466)
No single metric tells the full story. See the MMSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
83GF Score
Get the complete analysis for MMSI
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MMSI has been successfully added to your 
